Skip Navigation
Print Page

Neonatal Hypoglycemia: Opportunities & Challenges

Skip sharing on social media links
Share this:

September 8-9, 2008


Pregnancy and Perinatology Branch (PPB), Center for Developmental Biology and Perinatal Medicine (CDBPM), NICHD; NIH Office of Rare Diseases; Section on Perinatal Medicine of the American Academy of Pediatrics, and The March of Dimes Foundation


The Bolger Center, Potomac, Maryland


Neonatal hypoglycemia is the commonest metabolic problem encountered in newborn infants. Transient “hypoglycemia” can be viewed as an inevitable consequence of birth. Although it has been recognized for a long time, there is limited evidence-based consensus regarding the diagnosis, screening, and management of infants at risk for neonatal hypoglycemia. Some issues to be addressed in the workshop include: definition; risk factors; monitoring and screening; maternal management and prevention of neonatal hypoglycemia in an infant of a diabetic mother; the value of MRI as a diagnostic tool; and brain and blood glucose. The focus will be to identify knowledge gaps and propose a research agenda.


Dr. Tonse N. K. Raju, PPB, CDBPM, NICHD
Tel: (301) 402-1872
Fax: (301) 496-3790

Last Updated Date: 11/30/2012
Last Reviewed Date: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology